The Placebo Effect: Mechanisms and Methodology (R21)

The summary for the The Placebo Effect: Mechanisms and Methodology (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	The Placebo Effect: Mechanisms and Methodology (R21)
	CFDA Number:	93.213
	CFDA Description:	Research and Training in Complementary and Alternative Medicine
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-DA-12-004
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Feb 17, 2011
	Creation Date:	Feb 17, 2011
	Original Closing Date for Applications:	May 24, 2011
	Current Closing Date for Applications:	May 24, 2011
	Archive Date:	Jun 24, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description: This FOA will use the National Institutes of Health (NIH) Exploratory/Developmental Research Grant Award (R21) mechanism (to elucidate the underlying biological pathways that lead to placebo effects and to better understand how to recognize and enhance the therapeutic benefits of placebo effects in clinical research and practice.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-da-12-004.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Limited Competition: Strengthening Behavioral and Social Science in Medical School Education (R25); • Academic Career Award (Parent K07); • Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevent...; • Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevent...; • The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01); • Probiotics for Pediatric Illnesses; • CAM PRACTITIONER RESEARCH EDUCATION PROJECT GRANT PARTNERSHIP; • Complementary and Alternative Medicine Career Transition Award (K22); • Centers of Excellence for Research on Complementary and Alternative Medicine (CERC) [P01]; • Collaborative CAM Research Development Capability Enhancement Grant at Minority-Serving Institutions...